Insulin aspart, recombinant Subcutaneous and Nu-Iron
Determining the interaction of Insulin aspart, recombinant Subcutaneous and Nu-Iron and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: insulin aspart
Brand name: Fiasp, NovoLog, NovoLog FlexPen, NovoLog PenFill, NovoLOG FlexTouch, Fiasp PenFill, Fiasp FlexTouch
Synonyms: Insulin aspart, Insulin Aspart
Generic Name: iron polysaccharide
Brand name: Bifera, EZFE 200, Feosol Bifera, Ferrex 150, Ferric-x 150, Niferex, Niferex-150, Hytinic, Fe-Tinic 150, Polysaccharide Iron, Niferex Elixir, NovaFerrum Pediatric, Hematex, Iron Up, NovaFerrum Pediatric Drops, Ferrex 150 Plus
Synonyms: n.a.
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Insulin aspart, recombinant Subcutaneous-Nu-Iron 150
- Insulin aspart, recombinant Subcutaneous-Nu-Mag
- Insulin aspart, recombinant Subcutaneous-Nubain
- Insulin aspart, recombinant Subcutaneous-Nubeqa
- Insulin aspart, recombinant Subcutaneous-Nucofed Pediatric Expectorant
- Insulin aspart, recombinant Subcutaneous-NuCort
- Nu-Iron-Insulin degludec
- Nu-Iron-Insulin Degludec (U-100) Prefilled Pens
- Nu-Iron-Insulin Degludec (U-100) Vials
- Nu-Iron-Insulin Degludec (U-200) Prefilled Pens
- Nu-Iron-Insulin degludec and liraglutide
- Nu-Iron-Insulin degludec and liraglutide Subcutaneous